TARS
Tarsus Pharmaceuticals, Inc.
- Latest sale
- $980k
- Sep 15 · Routine
- Form 4 sales
- 148
- On record
- Form 144 notices
- 36
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJun 16 2026
Sold 14,396 shares at $60.95 ($877k)
Farrow Jeffrey S, Officer
No 10b5-1 planSold 20.2% of holdings ($4.3M position)56,801 shares left1.7x usual sizeFiling
- 2 Form 4 saleRoutineJun 17 +1 day
Sold 10,000 shares at $61.55 ($615k)
Azamian Bobak R., President/CEO and Board Chair
10b5-1 planSold 1.2% of holdings ($52.8M position)847,991 shares left1.7x usual sizeFiling
- 3 Form 4 saleRoutineSep 2 +77 days
Sold 10,000 shares at $80.06 ($801k)
Azamian Bobak R., President/CEO and Board Chair
10b5-1 planSold 1.2% of holdings ($67.9M position)837,991 shares left1.7x usual sizeFiling
- 4 Form 4 saleUnusualSep 2 same day
Sold 11,578 shares at $77.56 ($898k)
Lin Elizabeth Yeu, Chief Medical Officer
10b5-1 planSold 46.5% of holdings ($1.9M position)13,320 shares left10.1x usual sizeFiling
- 5 Form 4 saleRoutineSep 4 +2 days
Sold 4,564 shares at $85.00 ($388k)
Neervannan Seshadri, Chief Operating Officer
10b5-1 planSold 5.5% of holdings ($7.1M position)78,532 shares left0.6x usual sizeFiling
- 6 Form 4 saleRoutineSep 4 same day
Sold 10,000 shares at $90.56 ($906k)
Azamian Bobak R., President/CEO and Board Chair
10b5-1 planSold 1.2% of holdings ($75.9M position)827,991 shares left1.3x usual sizeFiling
- 7 Form 4 saleUnusualSep 4 same day
Sold 13,953 shares at $87.50 ($1.2M)
Lin Elizabeth Yeu, Chief Medical Officer
10b5-1 planSold 84.6% of holdings ($1.4M position)2,547 shares left8.7x usual sizeFiling
- 8 Form 4 saleRoutineSep 15 +11 days
Sold 12,500 shares at $78.38 ($980k)
Link William J Phd, Director
10b5-1 planSold 11.7% of holdings ($8.4M position)94,487 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (184)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Link William J Phd | Director | Form 4 sale | 12,500 | $980k | 11.7% | Routine | SEC |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Form 4 sale | 13,953 | $1.2M | 84.6% | Unusual | SEC |
| Sep 4, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 10,000 | $906k | 1.2% | Routine | SEC |
| Sep 4, 2026 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 4,564 | $388k | 5.5% | Routine | SEC |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Form 4 sale | 11,578 | $898k | 46.5% | Unusual | SEC |
| Sep 2, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 10,000 | $801k | 1.2% | Routine | SEC |
| Jun 17, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 10,000 | $615k | 1.2% | Routine | SEC |
| Jun 16, 2026 | Farrow Jeffrey S | Officer | Form 4 sale | 14,396 | $877k | 20.2% | No plan | SEC |
| Jun 15, 2026 | Goodrich Katherine | Director | Form 4 sale | 2,954 | $183k | 57.0% | Routine | SEC |
| Jun 15, 2026 | Link William J Phd | Director | Form 4 sale | 12,500 | $776k | 10.5% | Routine | SEC |
| Mar 20, 2026 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 2,989 | $200k | 3.5% | Routine | SEC |
| Mar 19, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Form 4 sale | 1,144 | $78k | 4.7% | No plan | SEC |
| Mar 19, 2026 | Wahl Bryan | General Counsel | Form 4 sale | 12,440 | $850k | 16.3% | No plan | SEC |
| Mar 19, 2026 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 12,274 | $839k | 25.9% | Unusual | SEC |
| Mar 19, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 34,603 | $2.4M | 50.9% | Unusual | SEC |
| Mar 19, 2026 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 11,324 | $772k | 11.7% | No plan | SEC |
| Mar 19, 2026 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 13,056 | $893k | 17.5% | No plan | SEC |
| Mar 19, 2026 | Farrow Jeffrey S | Officer | Form 4 sale | 6,430 | $440k | 12.9% | No plan | SEC |
| Mar 16, 2026 | Link William J Phd | Director | Form 4 sale | 12,500 | $860k | 9.7% | Routine | SEC |
| Mar 4, 2026 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 8,366 | $641k | 10.6% | Routine | SEC |
| Jan 2, 2026 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 15,565 | $1.3M | 40.0% | Routine | SEC |
| Dec 24, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 6,000 | $495k | 0.7% | Routine | SEC |
| Dec 16, 2025 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 7,397 | $592k | 16.0% | Routine | SEC |
| Dec 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Form 4 sale | 2,078 | $165k | 8.7% | No plan | SEC |
| Dec 15, 2025 | Link William J Phd | Director | Form 4 sale | 22,946 | $1.9M | 15.1% | Routine | SEC |
| Sep 24, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 6,000 | $332k | 0.7% | Routine | SEC |
| Sep 8, 2025 | Link William J Phd | Director | Form 4 sale | 27,116 | $1.5M | 15.9% | No plan | SEC |
| Aug 11, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 6,000 | $300k | 0.7% | Routine | SEC |
| Jun 17, 2025 | Farrow Jeffrey S | Officer | Form 4 sale | 13,608 | $550k | 27.0% | Unusual | SEC |
| Jun 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Form 4 sale | 1,006 | $41k | 11.6% | No plan | SEC |
| Jun 9, 2025 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 17,500 | $766k | 26.9% | Unusual | SEC |
| Mar 24, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 6,000 | $300k | 0.7% | No plan | SEC |
| Mar 20, 2025 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 10,565 | $506k | 14.0% | Unusual | SEC |
| Mar 20, 2025 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 7,583 | $363k | 8.7% | No plan | SEC |
| Mar 20, 2025 | Wahl Bryan | General Counsel | Form 4 sale | 9,686 | $464k | 15.8% | No plan | SEC |
| Mar 20, 2025 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 6,711 | $321k | 12.6% | No plan | SEC |
| Mar 20, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 24,216 | $1.2M | 31.1% | Unusual | SEC |
| Mar 20, 2025 | Farrow Jeffrey S | Officer | Form 4 sale | 3,724 | $178k | 14.2% | No plan | SEC |
| Aug 12, 2024 | Link William J Phd | Director | Form 4 sale | 35,000 | $913k | 100.0% | Unusual | SEC |
| Jun 18, 2024 | Farrow Jeffrey S | Officer | Form 4 sale | 10,445 | $287k | 36.5% | Unusual | SEC |
| Mar 18, 2024 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 4,766 | $146k | 8.1% | Unusual | SEC |
| Mar 18, 2024 | Wahl Bryan | General Counsel | Form 4 sale | 4,436 | $136k | 9.8% | Unusual | SEC |
| Mar 18, 2024 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 10,415 | $319k | 28.2% | Unusual | SEC |
| Mar 18, 2024 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 4,314 | $132k | 11.2% | Unusual | SEC |
| Mar 18, 2024 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 4,879 | $149k | 7.0% | Unusual | SEC |
| Dec 27, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $162k | 1.0% | Routine | SEC |
| Dec 20, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 40,000 | $811k | 4.6% | Unusual | SEC |
| Dec 20, 2023 | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Form 4 sale | 2,252 | $45k | 50.0% | Routine | SEC |
| Dec 20, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 40,000 | $811k | Notice | SEC | |
| Dec 20, 2023 | Trevejo Jose M. | Officer | Form 144 notice | 2,252 | $45k | Notice | SEC | |
| Nov 30, 2023 | Wahl Bryan | General Counsel | Form 4 sale | 8,356 | $136k | 20.7% | Unusual | SEC |
| Nov 30, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 8,355 | $136k | 23.8% | Unusual | SEC |
| Nov 30, 2023 | Whitfield Dianne C. | Officer | Form 144 notice | 8,355 | $136k | Notice | SEC | |
| Nov 30, 2023 | Wahl Bryan | Officer | Form 144 notice | 8,356 | $136k | Notice | SEC | |
| Nov 15, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $147k | 0.9% | Routine | SEC |
| Nov 15, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $147k | Notice | SEC | |
| Oct 18, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $106k | 0.9% | Routine | SEC |
| Oct 18, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $106k | Notice | SEC | |
| Oct 5, 2023 | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Form 4 sale | 1,604 | $29k | 26.3% | Routine | SEC |
| Oct 5, 2023 | Trevejo Jose M. | Officer | Form 144 notice | 1,604 | $29k | Notice | SEC | |
| Sep 20, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $138k | 0.9% | Routine | SEC |
| Sep 20, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $138k | Notice | SEC | |
| Aug 23, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $138k | 0.9% | Routine | SEC |
| Aug 23, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $138k | Notice | SEC | |
| Jul 20, 2023 | Greenstein Leonard M. | Former Officer | Form 144 notice | 5,000 | $113k | Notice | SEC | |
| Jul 19, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 103,900 | $2.1M | 10.2% | Unusual | SEC |
| Jul 19, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 2,400 | $48k | 5.0% | Routine | SEC |
| Jul 19, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 103,900 | $2.1M | Notice | SEC | |
| Jul 19, 2023 | Mottiwala Aziz | Officer | Form 144 notice | 2,400 | $48k | Notice | SEC | |
| Jul 12, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 9,000 | $156k | 0.9% | Routine | SEC |
| Jul 12, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 9,000 | $156k | Notice | SEC | |
| Jun 21, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $149k | 0.8% | Routine | SEC |
| Jun 21, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $149k | Notice | SEC | |
| Jun 15, 2023 | Greenstein Leonard M. | Former Chief Financial Officer | Form 144 notice | 5,000 | $92k | Notice | SEC | |
| Jun 14, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 9,000 | $167k | 0.9% | Routine | SEC |
| Jun 14, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 9,000 | $167k | Notice | SEC | |
| Jun 8, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 3,100 | $62k | 0.3% | Routine | SEC |
| Jun 8, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 100 | $2k | 0.2% | Routine | SEC |
| Jun 8, 2023 | Mottiwala Aziz | Officer | Form 144 notice | 100 | $2k | Notice | SEC | |
| Jun 8, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 3,100 | $62k | Notice | SEC | |
| Jun 7, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 4,643 | $88k | 8.8% | Unusual | SEC |
| Jun 7, 2023 | Mottiwala Aziz | Officer | Form 144 notice | 2,500 | $48k | Notice | SEC | |
| Jun 6, 2023 | Mottiwala Aziz | Officer | Form 144 notice | 2,143 | $40k | Notice | SEC | |
| May 18, 2023 | Greenstein Leonard M. | Officer | Form 144 notice | 5,000 | $80k | Notice | SEC | |
| May 17, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $127k | 0.8% | Routine | SEC |
| May 17, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $127k | Notice | SEC | |
| May 10, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 9,000 | $151k | 0.8% | Routine | SEC |
| May 10, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 9,000 | $151k | Notice | SEC | |
| May 1, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 10,119 | $153k | 0.9% | Routine | SEC |
| May 1, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 5,841 | $88k | Notice | SEC | |
| Apr 28, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 4,278 | $65k | Notice | SEC | |
| Apr 21, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 2,311 | $35k | 0.2% | Routine | SEC |
| Apr 21, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 2,311 | $35k | Notice | SEC | |
| Apr 20, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $70k | 15.7% | Routine | SEC |
| Apr 20, 2023 | Greenstein Leonard M. | Officer | Form 144 notice | 5,000 | $69k | Notice | SEC | |
| Apr 19, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $109k | 0.7% | Routine | SEC |
| Apr 19, 2023 | Azamian Bobak R. | Officer, Director | Form 144 notice | 8,000 | $109k | Notice | SEC | |
| Mar 23, 2023 | Wahl Bryan | General Counsel | Form 4 sale | 1,078 | $14k | 6.2% | No plan | SEC |
| Mar 23, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 1,004 | $13k | 8.2% | No plan | SEC |
| Mar 23, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 2,125 | $27k | 19.8% | No plan | SEC |
| Mar 23, 2023 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 1,141 | $14k | 2.0% | No plan | SEC |
| Mar 23, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 1,078 | $14k | 2.0% | No plan | SEC |
| Mar 23, 2023 | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Form 4 sale | 1,513 | $19k | 19.9% | No plan | SEC |
| Mar 23, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 1,004 | $13k | 3.1% | No plan | SEC |
| Mar 20, 2023 | Wahl Bryan | General Counsel | Form 4 sale | 696 | $9k | 3.8% | No plan | SEC |
| Mar 20, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 649 | $8k | 5.0% | No plan | SEC |
| Mar 20, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 1,536 | $20k | 12.5% | No plan | SEC |
| Mar 20, 2023 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 740 | $10k | 1.3% | No plan | SEC |
| Mar 20, 2023 | Holdbrook Mark J. | V.P., Clinical Affairs | Form 4 sale | 386 | $5k | 10.8% | No plan | SEC |
| Mar 20, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 697 | $9k | 1.3% | No plan | SEC |
| Mar 20, 2023 | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Form 4 sale | 1,034 | $13k | 11.9% | No plan | SEC |
| Mar 20, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 649 | $8k | 1.9% | No plan | SEC |
| Mar 16, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,791 | $121k | 0.8% | Plan not stated | SEC |
| Mar 16, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,313 | $71k | 13.7% | Plan not stated | SEC |
| Mar 16, 2023 | Holdbrook Mark J. | V.P., Clinical Affairs | Form 4 sale | 187 | $3k | 5.0% | Plan not stated | SEC |
| Mar 16, 2023 | Wahl Bryan | General Counsel | Form 4 sale | 337 | $5k | 1.8% | Plan not stated | SEC |
| Mar 16, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 313 | $4k | 2.4% | Plan not stated | SEC |
| Mar 16, 2023 | Trevejo Jose M. | Chief Medical Officer | Form 4 sale | 499 | $7k | 5.5% | Plan not stated | SEC |
| Mar 16, 2023 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 336 | $5k | 0.6% | Plan not stated | SEC |
| Mar 16, 2023 | Neervannan Seshadri | Chief Operating Officer | Form 4 sale | 357 | $5k | 0.6% | Plan not stated | SEC |
| Mar 16, 2023 | Greenstein Leonard M. | Officer | Form 144 notice | 5,000 | $67k | Notice | SEC | |
| Mar 16, 2023 | Mottiwala Aziz | Officer | Form 144 notice | 2,160 | $30k | Notice | SEC | |
| Mar 16, 2023 | Trevejo Jose M. | Officer | Form 144 notice | 3,240 | $44k | Notice | SEC | |
| Mar 16, 2023 | Holdbrook Mark J. | Officer | Form 144 notice | 1,200 | $16k | Notice | SEC | |
| Mar 16, 2023 | Whitfield Dianne C. | Officer | Form 144 notice | 2,015 | $28k | Notice | SEC | |
| Mar 16, 2023 | Wahl Bryan | Officer | Form 144 notice | 2,160 | $30k | Notice | SEC | |
| Mar 16, 2023 | Neervannan Seshadri | Officer | Form 144 notice | 2,300 | $31k | Notice | SEC | |
| Mar 16, 2023 | Greenstein Leonard M. | Officer | Form 144 notice | 2,015 | $28k | Notice | SEC | |
| Mar 9, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 5,570 | $84k | 0.5% | Plan not stated | SEC |
| Feb 16, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $76k | 12.7% | Plan not stated | SEC |
| Feb 15, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $122k | 0.7% | Plan not stated | SEC |
| Feb 8, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 9,000 | $136k | 0.8% | Plan not stated | SEC |
| Jan 23, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 4,856 | $75k | 0.4% | Plan not stated | SEC |
| Jan 20, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,240 | $120k | 0.7% | Plan not stated | SEC |
| Jan 19, 2023 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $73k | 11.3% | Plan not stated | SEC |
| Jan 11, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 3,904 | $59k | 0.3% | Plan not stated | SEC |
| Jan 10, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 1,634 | $25k | 0.1% | Plan not stated | SEC |
| Jan 6, 2023 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 411 | $6k | 0.0% | Plan not stated | SEC |
| Dec 21, 2022 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 8,000 | $117k | 0.7% | Plan not stated | SEC |
| Dec 16, 2022 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 535 | $8k | 0.0% | Plan not stated | SEC |
| Dec 15, 2022 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $73k | 10.1% | Plan not stated | SEC |
| Dec 14, 2022 | Azamian Bobak R. | President/CEO and Board Chair | Form 4 sale | 6,420 | $97k | 0.6% | Plan not stated | SEC |
| Dec 2, 2022 | Wahl Bryan | General Counsel | Form 4 sale | 1,154 | $20k | 7.8% | Plan not stated | SEC |
| Dec 2, 2022 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 1,154 | $20k | 11.7% | Plan not stated | SEC |
| Dec 1, 2022 | Wahl Bryan | General Counsel | Form 4 sale | 2,347 | $39k | 13.6% | Plan not stated | SEC |
| Dec 1, 2022 | Whitfield Dianne C. | Chief Human Resources Officer | Form 4 sale | 2,347 | $39k | 19.2% | Plan not stated | SEC |
| Nov 17, 2022 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $83k | 9.2% | Plan not stated | SEC |
| Nov 16, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 8,000 | $135k | 0.7% | Plan not stated | SEC |
| Nov 15, 2022 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 6,857 | $122k | 12.1% | Unusual | SEC |
| Nov 9, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 9,000 | $161k | 0.8% | Plan not stated | SEC |
| Oct 20, 2022 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $80k | 8.4% | Plan not stated | SEC |
| Oct 19, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 8,000 | $135k | 0.7% | Plan not stated | SEC |
| Oct 12, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 9,000 | $143k | 0.8% | Plan not stated | SEC |
| Sep 21, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 8,000 | $130k | 0.7% | Plan not stated | SEC |
| Sep 15, 2022 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $80k | 7.8% | Plan not stated | SEC |
| Sep 14, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 9,000 | $144k | 0.8% | Plan not stated | SEC |
| Aug 18, 2022 | Greenstein Leonard M. | Chief Financial Officer | Form 4 sale | 5,000 | $82k | 7.2% | Plan not stated | SEC |
| Aug 17, 2022 | Azamian Bobak R. | President and CEO | Form 4 sale | 8,000 | $133k | 0.7% | Plan not stated | SEC |
| May 5, 2022 | Vivo Capital IX, LLC | 10% owner | Form 4 sale | 5,374 | $66k | 0.2% | Plan not stated | SEC |
| May 4, 2022 | Vivo Capital Fund IX, L.P. | 10% owner | Form 4 sale | 512,956 | $6.9M | 17.2% | Plan not stated | SEC |
| Dec 1, 2021 | Ackermann Michael | Director | Form 4 sale | 5,833 | $144k | 0.5% | Plan not stated | SEC |
| Dec 1, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 5,833 | $144k | 0.5% | Plan not stated | SEC |
| Nov 8, 2021 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 1,889 | $53k | 3.6% | Plan not stated | SEC |
| Nov 5, 2021 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 111 | $3k | 0.2% | Plan not stated | SEC |
| Nov 2, 2021 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 6,000 | $161k | 10.3% | Plan not stated | SEC |
| Nov 1, 2021 | Ackermann Michael | Director | Form 4 sale | 5,833 | $162k | 0.5% | Plan not stated | SEC |
| Nov 1, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 5,833 | $162k | 0.5% | Plan not stated | SEC |
| Oct 12, 2021 | Ackermann Michael | Director | Form 4 sale | 5,633 | $148k | 0.5% | Unusual | SEC |
| Oct 12, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 5,531 | $145k | 0.5% | Plan not stated | SEC |
| Oct 8, 2021 | Ackermann Michael | Director | Form 4 sale | 200 | $5k | 0.0% | Plan not stated | SEC |
| Oct 8, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 302 | $8k | 0.0% | Plan not stated | SEC |
| Sep 10, 2021 | Mottiwala Aziz | Chief Commercial Officer | Form 4 sale | 2,593 | $57k | 4.3% | Plan not stated | SEC |
| Sep 1, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 5,833 | $147k | 0.5% | Plan not stated | SEC |
| Sep 1, 2021 | Ackermann Michael | Director | Form 4 sale | 5,833 | $147k | 0.5% | Unusual | SEC |
| Aug 11, 2021 | Ackermann Michael | Director | Form 4 sale | 621 | $16k | 0.1% | Plan not stated | SEC |
| Aug 11, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 2,020 | $51k | 0.2% | Plan not stated | SEC |
| Aug 9, 2021 | Ackermann Michael | Director | Form 4 sale | 3,829 | $96k | 0.3% | Plan not stated | SEC |
| Aug 9, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 2,443 | $61k | 0.2% | Plan not stated | SEC |
| Aug 5, 2021 | Ackermann Michael | Director | Form 4 sale | 1,383 | $35k | 0.1% | Plan not stated | SEC |
| Aug 5, 2021 | Azamian Bobak R. | President and CEO | Form 4 sale | 1,370 | $34k | 0.1% | Plan not stated | SEC |
| Jun 25, 2021 | Vivo Capital IX, LLC | 10% owner | Form 4 sale | 55,684 | $1.7M | 1.8% | Plan not stated | SEC |
| Jun 22, 2021 | Vivo Capital IX, LLC | 10% owner | Form 4 sale | 201,620 | $5.9M | 6.2% | Plan not stated | SEC |
| May 7, 2021 | Rtw Investments, LP | 10% owner | Form 4 sale | 450,000 | $13.5M | 18.3% | Plan not stated | SEC |
| Apr 14, 2021 | Vivo Capital IX, LLC | 10% owner | Form 4 sale | 400 | $12k | 0.0% | Plan not stated | SEC |